JeffreyToretskyMD

Pediatric Hematology & Oncology • Washington, DC

Professor; Molecular Oncology Program Co-leader, Lombardi Comprehensive Cancer Center (LCCC), Division Chief Pediatric Adolescent and Young Adult Heme/Onc Medstar Georgetown University Hospital

Join to view full profile

Dr. Toretsky is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Toretsky's full profile

Already have an account?

Office
3800 Reservoir Rd Nw
web: toretsky.georgetown.edu
Washington, DC 20007
Phone+1 202-444-7599

Education & Training

National Cancer InstituteFellowship, Pediatric Hematology/Oncology, 1991 - 1994
Virginia Commonwealth University Health SystemResidency, Pediatrics, 1989 - 1991
Duke University HospitalInternship, Pediatrics, 1988 - 1989
University of Minnesota Medical SchoolClass of 1988

Certifications & Licensure

DC State Medical License 2002 - 2024
PA State Medical License 2014 - 2016
MD State Medical License 1991 - 2011
NC State Medical License 1988 - 1999
American Board of Pediatrics Pediatric Hematology-Oncology

Awards, Honors, & Recognition

Fellow National Academy of Inventors, 2018
Elected Member The American Society for Clinical Investigation, 2007

Clinical Trials

Web-Based Physical Activity Intervention in Improving Long Term Health in Children and Adolescents With Cancer Start of enrollment: 2017 Nov 29
Active, not recruiting
Phase 3
Irinotecan Hydrochloride, Temozolomide, and Dinutuximab With or Without Eflornithine in Treating Patients With Relapsed or Refractory Neuroblastoma Start of enrollment: 2019 Jul 08
Active, not recruiting
Phase 2
A Study to Investigate Blinatumomab in Combination With Chemotherapy in Patients With Newly Diagnosed B-Lymphoblastic Leukemia Start of enrollment: 2019 Jul 03
Recruiting
Phase 3

Publications & Presentations

PubMed

16 citations
Insulin-Like Growth Factor 1 Receptor as a Therapeutic Target in Ewing Sarcoma: Lack of Consistent Upregulation or Recurrent Mutation and a Review of the Clinical Tria...
Alison O'Neill, Nilay Shah, Naamah L. Zitomersky, Marc Ladanyi, Aykut Üren
Sarcoma. 2013-01-28
36 citations
The ETS Inhibitors YK-4-279 and TK-216 Are Novel Antilymphoma Agents
Filippo Spriano, Elaine Yee Lin Chung, Eugenio Gaudio, Chiara Tarantelli, Luciano Cascione
Clinical Cancer Research. 2019-08-15
132 citations
EWS–FLI1 increases transcription to cause R-loops and block BRCA1 repair in Ewing sarcoma
Aparna Gorthi, July Carolina Romero, Eva Loranc, Lin Cao, Liesl A. Lawrence
Nature. 2018-03-15

Journal Articles

Author Correction: EWS–FLI1 Increases Transcription to Cause R-loops and Block BRCA1 Repair in Ewing Sarcoma
Kimberly Stegmaier, Stephen L Lessnick, Jeffrey A Toretsky, Nature

Press Mentions

DC Hospital’s Comprehensive Program Extends Beyond Medical Care to Help Young Cancer PatientsMay 17th, 2022
Adolescent and Young Adult Cancer Survivors Benefit from Area’s Only Program to Support Their Unique NeedsApril 25th, 2022
Oncternal Therapeutics Announces Presentation of Two Abstracts at ASCO 2021 Virtual MeetingApril 28th, 2021
Join now to see all

Grant Support

Novel Compounds To Inactivate Oncogenic Fusion ProteinsNational Cancer Institute2009–2012
Isolation And Small Molecule Targeting Of Ewing'S Sarcoma Stem CellsNational Cancer Institute2008–2011
YK-4-279 Specifically Targets ETS Family Fusion-Protein Cancers In Clinical TrialNational Cancer Institute2010
Signaling Pathways That Determine Ewings Sarcoma OutcomeNational Cancer Institute2004–2008
Biacore T100: ProteomicsNational Center For Research Resources2006
Biacore T100: Prostate CancerNational Center For Research Resources2006
Biacore T100: CancerNational Center For Research Resources2006
Biacore T100: Breast CancerNational Center For Research Resources2006
Biacore T100National Center For Research Resources2006
AKT Inhibitors To Treat Ewing'S SarcomaNational Cancer Institute2004–2005
Role Of IGF Signaling Upon Ewings Sarcoma PatientNational Cancer Institute2002–2003
Role Of IGF Signaling Upon Ewings Sarcoma PatientNational Cancer Institute2001